Neither FAMS nor phyre2 predicted a significant tertiary structure for PMEPA1, a transmembrane prostate androgen-induced protein that enhances tumorigenic activity in lung cancer cells [32]. The gene discussed is PMEPA1; the disease is lung carcinoma.